Hudson Bay Capital Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $27.8K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $48.4K | Sell |
|
|||||
|
2024
Q1 | $921K | Sell |
|
|||||
|
2023
Q4 | $1.36M | Buy |
|
|||||
|
2023
Q3 | $779K | Sell |
|
|||||
|
2023
Q2 | $1.72M | Buy |
|
|||||
|
2023
Q1 | $2.11M | Buy |
|
|||||
|
2022
Q4 | $3.63M | Buy |
|
|||||
|
2022
Q3 | $4.41M | Hold |
|
|||||
|
2022
Q2 | $3.73M | Buy |
|
|||||
|
2022
Q1 | $4.53M | Buy |
|
|||||
|
2021
Q4 | $4.5M | Buy |
|
|||||
|
2021
Q3 | $4.28M | Buy |
|
|||||
|
2021
Q2 | $5.39M | Buy |
|
|||||
|
2021
Q1 | $4.2M | Sell |
|
|||||
|
2020
Q4 | $5.62M | Sell |
|
|||||
|
2020
Q3 | $4.54M | Sell |
|
|||||
|
2020
Q2 | $4.66M | Sell |
|
|||||
|
2020
Q1 | $4.3M | Buy |
|
|||||
|
2019
Q4 | $2.18M | Buy |
|
|||||
|
2019
Q3 | $1.63M | Sell |
|
|||||
|
2019
Q2 | $2.15M | Buy |
|
|||||
|
2019
Q1 | $286K | Hold |
|
|||||
|
2018
Q4 | $344K | Buy |
|
|||||
|
2018
Q3 | $339K | Sell |
|
|||||
|
2018
Q2 | $426K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $396K | Buy |
|